The pharmaceutical industry stands on the brink of a radical transformation, driven by the integration of advanced technologies such as artificial intelligence (AI) and quantum computing. Sanofi, a sector leader, exemplifies this trend by incorporating AI into drug research and development (R&D). Concurrently, initiatives like Prometheus, backed by Jeff Bezos with a monumental investment of $12 billion, aim to revolutionize pharmaceutical engineering through an "artificial general engineer." These innovations promise to disrupt traditional drug discovery paradigms but also pose significant regulatory and ethical challenges.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
